CIK 0001477449 · Large accelerated filer
Teladoc Health, Inc.
Sign in to watch- Ticker
- TDOC
- Exchange
- NYSE
- Industry
- Services-Offices & Clinics of Doctors of Medicine
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 043705970
- Phone
- 2036352002
- Business address
- 155 E 44TH STREET, SUITE 1700, NEW YORK, NY, 10017
- Former names
- Teladoc, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $731,651
- in 9 filings, $369K under 10b5-1 plans
Net −$731,651. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
- Nueno Carlos −$310K President, International sold 50% of stake
- DIVITA CHARLES III −$224K CHIEF EXECUTIVE OFFICER sold 7% of stake
- Rodrigues Fernando M. −$98K President of BetterHelp sold 100% of stake
- Vandervoort Adam C −$48K CHIEF LEGAL OFFICER, SECRETARY sold 6% of stake
- Bliss Kelly −$46K President, U.S. Group Health sold 7% of stake
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2021-04-19 | Taneja Hemant Director | Sale | −300 | $190.69 | $57K | 118,760 |
| 2021-04-14 | Trencher Daniel SVP Corporate Strategy | Option exercise | +2,173 | $12.21 | $27K | 16,680 |
| 2021-04-14 | Trencher Daniel SVP Corporate Strategy | Option exercise | +6,404 | $22.30 | $143K | 23,084 |
| 2021-04-14 | Trencher Daniel SVP Corporate Strategy | Option exercise | +590 | $38.55 | $23K | 23,674 |
| 2021-04-14 | Trencher Daniel SVP Corporate Strategy | Option exercise · Employee Stock Option (right to buy) | −2,173 | 0 | ||
| 2021-04-14 | Trencher Daniel SVP Corporate Strategy | Option exercise · Employee Stock Option (right to buy) | −6,404 | 31,242 | ||
| 2021-04-14 | Trencher Daniel SVP Corporate Strategy | Option exercise · Employee Stock Option (right to buy) | −590 | 30,800 | ||
| 2021-04-12 | Trencher Daniel SVP Corporate Strategy | Option exercise | +2,000 | $22.30 | $45K | 16,507 |
| 2021-04-12 | Trencher Daniel SVP Corporate Strategy | Sale | −2,000 | $181.00 | $362K | 14,507 |
| 2021-04-12 | Trencher Daniel SVP Corporate Strategy | Option exercise · Employee Stock Option (right to buy) | −2,000 | 37,646 | ||
| 2021-04-06 | GOREVIC JASON N Chief Executive Officer | Sale | −3,000 | $180.86 | $543K | 507,970 |
| 2021-04-06 | GOREVIC JASON N Chief Executive Officer | Sale | −8,056 | $181.55 | $1.5M | 499,914 |
| 2021-04-06 | GOREVIC JASON N Chief Executive Officer | Sale | −10,054 | $182.62 | $1.8M | 489,860 |
| 2021-04-06 | GOREVIC JASON N Chief Executive Officer | Sale | −3,790 | $183.42 | $695K | 486,070 |
| 2021-04-06 | GOREVIC JASON N Chief Executive Officer | Sale | −100 | $184.18 | $18K | 485,970 |
| 2021-04-01 | TULLMAN GLEN Director | Option exercise | +329,863 | $5.26 | $1.7M | 605,656 |
| 2021-04-01 | TULLMAN GLEN Director | Sale | −60,148 | $182.78 | $11.0M | 545,508 |
| 2021-04-01 | TULLMAN GLEN Director | Sale | −45,089 | $183.78 | $8.3M | 500,419 |
| 2021-04-01 | TULLMAN GLEN Director | Sale | −44,825 | $184.68 | $8.3M | 455,594 |
| 2021-04-01 | TULLMAN GLEN Director | Sale | −24,759 | $185.80 | $4.6M | 430,835 |
Page 73 of 74 · 1,476 trades